(MENAFN- EIN Presswire) EINPresswire/ -- Researchers at Monash University in Australia have discovered that female mice modeling anorexia nervosa display a behavioral signature associated with ...
Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and ...
UW-Madison researchers are studying the therapeutic potential of psychedelic drugs like psilocybin for treating addiction, depression, and PTSD. Concerns remain about post-treatment care and the need ...
As a psychologist who has served as a therapist and site co-principal investigator in clinical trials of MDMA and psilocybin, I'm often asked what conditions psychedelic therapy can treat and how it ...
What happens when AI pretends to be on psychedelic drugs? Does it trip out? Recent research reveals the mystery. An AI ...
A gentle LA breeze floats through a wall of green plants as you watch a butterfly flap its wings in the air. A friendly person hands you an ecstasy pill over the sound of gently gurgling water. It ...
Vancouver, Canada, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and ...
Vancouver, Canada, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and ...
As acceptance of psychedelic therapies continues to grow within the medical community, building a robust intellectual property portfolio establishes Clearmind as a pioneer and leader in the next ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results